Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SR 141716A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Darmani, NA
      Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A

      NEUROPSYCHOPHARMACOLOGY
    2. Lichtman, AH; Poklis, JL; Poklis, A; Wilson, DM; Martin, BR
      The pharmacological activity of inhalation exposure to marijuana smoke in mice

      DRUG AND ALCOHOL DEPENDENCE
    3. Kunos, G; Batkai, S
      Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice

      NEUROCHEMICAL RESEARCH
    4. Braida, D; Pozzi, M; Cavallini, R; Sala, M
      Conditioned place preference induced by the cannabinoid agonist CP 55,940:Interaction with the opioid system

      NEUROSCIENCE
    5. Maingret, F; Patel, AJ; Lazdunski, M; Honore, E
      The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1

      EMBO JOURNAL
    6. Garcia, N; Jarai, Z; Mirshahi, F; Kunos, G; Sanyal, AJ
      Systemic and portal hemodynamic effects of anandamide

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    7. Arevalo, C; de Miguel, R; Hernandez-Tristan, R
      Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    8. Lichtman, AH; Fisher, J; Martin, BR
      Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    9. Darmani, NA
      Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    10. Darmani, NA
      Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    11. Nava, F; Carta, G; Colombo, G; Gessa, GL
      Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze

      NEUROPHARMACOLOGY
    12. Clarke, RW; Harris, J; Jenkins, S; Witton, SK
      Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit

      NEUROPHARMACOLOGY
    13. Kathmann, M; Weber, B; Schlicker, E
      Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    14. Cravatt, BF; Demarest, K; Patricelli, MP; Bracey, MH; Giang, DK; Martin, BR; Lichtman, AH
      Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    15. Mancinelli, R; Fabrizi, A; Del Monaco, S; Azzena, GB; Vargiu, R; Colombo, GC; Gessa, GL
      Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse

      LIFE SCIENCES
    16. Lichtman, AH; Sheikh, SM; Loh, HH; Martin, BR
      Opioid and cannabinoid modulation of precipitated withdrawal in Delta(9)-tetrahydrocannabinol and morphine-dependent mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    17. Pertwee, RG
      Cannabinoids and the gastrointestinal tract

      GUT
    18. da Silva, GE; Morato, GS; Takahashi, RN
      Rapid tolerance to Delta(9)-tetrahydrocannabinol and cross-tolerance between ethanol and Delta(9)-tetrahydrocannabinol in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Darmani, NA
      The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemeticand motor depressant actions of WIN 55, 212-2

      EUROPEAN JOURNAL OF PHARMACOLOGY
    20. Di Marzo, V; Lastres-Becker, I; Bisogno, T; De Petrocellis, L; Milone, A; Davis, JB; Fernandez-Ruiz, JJ
      Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Acquas, E; Pisanu, A; Marrocu, P; Goldberg, SR; Di Chiara, G
      Delta(9)-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Aceto, MD; Scates, SM; Martin, BB
      Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Kathmann, M; Weber, B; Zimmer, A; Schlicker, E
      Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice

      BRITISH JOURNAL OF PHARMACOLOGY
    24. Christopoulos, A; Coles, P; Lay, L; Lew, MJ; Angus, JA
      Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens

      BRITISH JOURNAL OF PHARMACOLOGY
    25. Huestis, MA; Gorelick, DA; Heishman, SJ; Preston, KL; Nelson, RA; Moolchan, ET; Frank, RA
      Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716

      ARCHIVES OF GENERAL PSYCHIATRY
    26. Fattore, L; Cossu, G; Martellotta, CM; Fratta, W
      Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

      PSYCHOPHARMACOLOGY
    27. Walker, JM; Huang, SM; Strangman, NM; Sanudo-Pena, MC
      Identification of the role of endogenous cannabinoids in pain modulation: Strategies and pitfalls

      JOURNAL OF PAIN
    28. Pertwee, RG
      Neuropharmacology and therapeutic potential of cannabinoids

      ADDICTION BIOLOGY
    29. Braida, D; Sala, M
      Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats

      NEUROREPORT
    30. Nakamura-Palacios, EM; Winsauer, PJ; Moerschbaecher, JM
      Effects of the cannabinoid ligand SR 141716A alone or in combination with Delta(9)-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys

      BEHAVIOURAL PHARMACOLOGY
    31. Cosenza, M; Gifford, AN; Gatley, SJ; Pyatt, B; Liu, Q; Makriyannis, A; Volkow, ND
      Locomotor activity and occupancy of brain cannabinoid CB1 receptors by theantagonist/inverse agonist AM281

      SYNAPSE
    32. Rubino, T; Vigano, D; Zagato, E; Sala, M; Parolaro, D
      In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments

      SYNAPSE
    33. Greenwald, MK; Stitzer, ML
      Antinociceptive, subjective and behavioral effects of smoked marijuana in humans

      DRUG AND ALCOHOL DEPENDENCE
    34. Darmani, NA; Pandya, DK
      Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

      JOURNAL OF NEURAL TRANSMISSION
    35. Di Marzo, V; Breivogel, CS; Tao, Q; Bridgen, DT; Razdan, RK; Zimmer, AM; Zimmer, A; Martin, BR
      Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain

      JOURNAL OF NEUROCHEMISTRY
    36. Howlett, AC; Wilken, GH; Pigg, JJ; Houston, DB; Lan, RX; Liu, Q; Makriyannis, A
      Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction

      JOURNAL OF NEUROCHEMISTRY
    37. Acquas, E; Pisanu, A; Marrocu, P; Di Chiara, G
      Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. Lichtman, AH; Peart, J; Poklis, JL; Bridgen, DT; Razdan, RK; Wilson, DM; Poklis, A; Mung, Y; Byron, PR; Martin, BR
      Pharmacological evaluation of aerosolized cannabinoids in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    39. Lay, L; Angus, JA; Wright, CE
      Pharmacological characterisation of cannabinoid CB1 receptors in the rat and mouse

      EUROPEAN JOURNAL OF PHARMACOLOGY
    40. Nava, F; Carta, G; Battasi, AM; Gessa, GL
      D-2 dopamine receptors enable Delta(9)-tetrahydrocannabinol induced memoryimpairment and reduction of hippocampal extracellular acetylcholine concentration

      BRITISH JOURNAL OF PHARMACOLOGY
    41. Coutts, AA; Brewster, N; Ingram, T; Razdan, RK; Pertwee, RG
      Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine

      BRITISH JOURNAL OF PHARMACOLOGY
    42. Sharpe, P; Smith, G
      Cannabis: Time for scientific evaluation of this ancient remedy?

      ANESTHESIA AND ANALGESIA
    43. Costa, B; Giagnoni, G; Colleoni, M
      Precipitated and spontaneous withdrawal in rats tolerant to anandamide

      PSYCHOPHARMACOLOGY
    44. Valjent, E; Maldonado, R
      A behavioural model to reveal place preference to Delta 9-tetrahydrocannabinol in mice

      PSYCHOPHARMACOLOGY
    45. Pop, E
      Cannabinoids, endogenous ligands and synthetic analogs

      CURRENT OPINION IN CHEMICAL BIOLOGY
    46. Yousif, MHM; Oriowo, MA
      Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments

      PHARMACOLOGICAL RESEARCH
    47. Winsauer, PJ; Lambert, P; Moerschbaecher, JM
      Cannabinoid ligands and their effects on learning and performance in rhesus monkeys

      BEHAVIOURAL PHARMACOLOGY
    48. Masserano, JM; Karoum, F; Wyatt, RJ
      SR141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine

      BEHAVIOURAL PHARMACOLOGY
    49. Costa, B; Vailati, S; Colleoni, M
      SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats

      BEHAVIOURAL PHARMACOLOGY
    50. Sagan, S; Venance, L; Torrens, Y; Cordier, J; Glowinski, J; Giaume, C
      Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes

      EUROPEAN JOURNAL OF NEUROSCIENCE
    51. Pertwee, RG
      Pharmacology of cannabinoid receptor ligands

      CURRENT MEDICINAL CHEMISTRY
    52. Barth, F; Rinaldi-Carmona, M
      The development of cannabinoid antagonists

      CURRENT MEDICINAL CHEMISTRY
    53. Gebremedhin, D; Lange, AR; Campbell, WB; Hillard, CJ; Harder, DR
      Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    54. Alonso, R; Voutsinos, B; Fournier, M; Labie, C; Steinberg, R; Souilhac, J; Le Fur, G; Soubrie, P
      Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D-2 function

      NEUROSCIENCE
    55. Costa, B; Colleoni, M
      SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists

      ACTA PHARMACOLOGICA SINICA
    56. Sanudo-Pena, MC; Force, M; Kang, T; McLemore, G; Roberts, L; Walker, JM
      Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome

      ACTA PHARMACOLOGICA SINICA
    57. Fattore, L; Martellotta, MC; Cossu, G; Mascia, MS; Fratta, W
      CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats

      BEHAVIOURAL BRAIN RESEARCH
    58. Fuentes, JA; Ruiz-Gayo, M; Manzanares, J; Vela, G; Reche, I; Corchero, J
      Cannabinoids as potential new analgesics

      LIFE SCIENCES
    59. Lan, RX; Liu, Q; Fan, PS; Lin, SY; Fernando, SR; McCallion, D; Pertwee, R; Makriyannis, A
      Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    60. Bouaboula, M; Bianchini, L; McKenzie, FR; Pouyssegur, J; Casellas, P
      Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via G(i)-mediated mitogen activated protein kinase signaling transduction pathways

      FEBS LETTERS
    61. Carta, G; Gessa, GL; Nava, F
      Dopamine D-2 receptor antagonists prevent Delta(9)-tetrahydrocannabinol-induced antinociception in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    62. Krowicki, ZK; Moerschbaecher, JM; Winsauer, PJ; Digavalli, SV; Hornby, PJ
      Delta(9)-tetrahydrocannabinol inhibits gastric motility in the rat throughcannabinoid CB1 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    63. Manzanares, J; Corchero, J; Fuentes, JA
      Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of Delta(9)-tetrahydrocannabinol in rats

      BRAIN RESEARCH
    64. Manzanares, J; Corchero, J; Romero, J; Fernandez-Ruiz, JJ; Ramos, JA; Fuentes, JA
      Pharmacological and biochemical interactions between opioids and cannabinoids

      TRENDS IN PHARMACOLOGICAL SCIENCES
    65. Lichtman, AH; Martin, BR
      Analgesic properties of THC and its synthetic derivatives

      MARIHUANA AND MEDICINE
    66. Koe, BK
      Levonantradol

      MARIHUANA AND MEDICINE
    67. BARTH F
      CANNABINOID RECEPTOR AGONISTS AND ANTAGONISTS

      Expert opinion on therapeutic patents
    68. Piomelli, D; Beltramo, M; Giuffrida, A; Stella, N
      Endogenous cannabinoid signaling

      NEUROBIOLOGY OF DISEASE
    69. Consroe, P
      Brain cannabinoid systems as targets for the therapy of neurological disorders

      NEUROBIOLOGY OF DISEASE
    70. MARTELLOTTA MC; COSSU G; FATTORE L; GESSA GL; FRATTA W
      SELF-ADMINISTRATION OF THE CANNABINOID RECEPTOR AGONIST WIN-55,212-2 IN DRUG-NAIVE MICE

      Neuroscience
    71. RICHARDSON JD; AANONSEN L; HARGREAVES KM
      HYPOACTIVITY OF THE SPINAL CANNABINOID SYSTEM RESULTS IN NMDA-DEPENDENT HYPERALGESIA

      The Journal of neuroscience
    72. ACETO MD; SCATES SM; RAZDAN RK; MARTIN BR
      ANANDAMIDE, AN ENDOGENOUS CANNABINOID, HAS A VERY-LOW PHYSICAL-DEPENDENCE POTENTIAL

      The Journal of pharmacology and experimental therapeutics
    73. DEROCQ JM; BOUABOULA M; MARCHAND J; RINALDICARMONA M; SEGUI M; CASELLAS P
      THE ENDOGENOUS CANNABINOID ANANDAMIDE IS A LIPID MESSENGER ACTIVATINGCELL-GROWTH VIA A CANNABINOID RECEPTOR-INDEPENDENT PATHWAY IN HEMATOPOIETIC-CELL LINES

      FEBS letters
    74. LICHTMAN AH; WILEY JL; LAVECCHIA KL; NEVIASER ST; ARTHUR DB; WILSON DM; MARTIN BR
      EFFECTS OF SR 141716A AFTER ACUTE OR CHRONIC CANNABINOID ADMINISTRATION IN DOGS

      European journal of pharmacology
    75. GESSA GL; CASU MA; CARTA G; MASCIA MS
      CANNABINOIDS DECREASE ACETYLCHOLINE-RELEASE IN THE MEDIAL-PREFRONTAL CORTEX AND HIPPOCAMPUS, REVERSAL BY SR 141716A

      European journal of pharmacology
    76. COLOMBO G; AGABIO R; LOBINA C; REALI R; GESSA GL
      CANNABINOID MODULATION OF INTESTINAL PROPULSION IN MICE

      European journal of pharmacology
    77. WHITE R; HILEY CR
      THE ACTIONS OF THE CANNABINOID RECEPTOR ANTAGONIST, SR 141716A, IN THE RAT ISOLATED MESENTERIC-ARTERY

      British Journal of Pharmacology
    78. WHITE R; HILEY CR
      THE ACTIONS OF SOME CANNABINOID RECEPTOR LIGANDS IN THE RAT ISOLATED MESENTERIC-ARTERY

      British Journal of Pharmacology
    79. Hutcheson, DM; Tzavara, ET; Smadja, C; Valjent, E; Roques, BP; Hanoune, J; Maldonado, R
      Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Delta-9-tetrahydrocannabinol

      BRITISH JOURNAL OF PHARMACOLOGY
    80. STRANGMAN NM; PATRICK SL; HOHMANN AG; TSOU K; WALKER JM
      EVIDENCE FOR A ROLE OF ENDOGENOUS CANNABINOIDS IN THE MODULATION OF ACUTE AND TONIC PAIN SENSITIVITY

      Brain research
    81. NAVARRO M; HERNANDEZ E; MUNOZ RM; DELARCO I; VILLANUA MA; CARRERA MRA; DEFONSECA FR
      ACUTE ADMINISTRATION OF THE CB1 CANNABINOID RECEPTOR ANTAGONIST SR 141716A INDUCES ANXIETY-LIKE RESPONSES IN THE RAT

      NeuroReport
    82. LICHTMAN AH; MARTIN BR
      THE SELECTIVE CANNABINOID ANTAGONIST SR 141716A BLOCKS CANNABINOID-INDUCED ANTINOCICEPTION IN RATS

      Pharmacology, biochemistry and behavior
    83. JUNG M; CALASSI R; RINALDICARMONA M; CHARDENOT P; LEFUR G; SOUBRIE P; OURYDONAT F
      CHARACTERIZATION OF CB1 RECEPTORS ON RAT NEURONAL CELL-CULTURES - BINDING AND FUNCTIONAL-STUDIES USING THE SELECTIVE RECEPTOR ANTAGONIST SR141716A

      Journal of neurochemistry
    84. GIFFORD AN; SAMIIAN L; GATLEY SJ; ASHBY CR
      EXAMINATION OF THE EFFECT OF THE CANNABINOID RECEPTOR AGONIST, CP-55,940, ON ELECTRICALLY-EVOKED TRANSMITTER RELEASE FROM RAT-BRAIN SLICES

      European journal of pharmacology
    85. MANEUF YP; BROTCHIE JM
      PARADOXICAL ACTION OF THE CANNABINOID WIN-55,212-2 IN STIMULATED AND BASAL CYCLIC-AMP ACCUMULATION IN RAT GLOBUS-PALLIDUS SLICES

      British Journal of Pharmacology
    86. PERIO A; RINALDICARMONA M; MARUANI J; BARTH F; LEFUR G; SOUBRIE P
      CENTRAL MEDIATION OF THE CANNABINOID CUE - ACTIVITY OF A SELECTIVE CB1 ANTAGONIST, SR 141716A

      Behavioural pharmacology
    87. SANTUCCI V; STORME JJ; SOUBRIE P; LEFUR G
      AROUSAL-ENHANCING PROPERTIES OF THE CB1 CANNABINOID RECEPTOR ANTAGONIST SR 141716A IN RATS AS ASSESSED BY ELECTROENCEPHALOGRAPHIC SPECTRAL AND SLEEP-WAKING CYCLE ANALYSIS

      Life sciences
    88. RINALDICARMONA M; PIALOT F; CONGY C; REDON E; BARTH F; BACHY A; BRELIERE JC; SOUBRIE P; LEFUR G
      CHARACTERIZATION AND DISTRIBUTION OF BINDING-SITES FOR [H-3] SR 141716A, A SELECTIVE BRAIN (CB1) CANNABINOID RECEPTOR ANTAGONIST, IN RODENTBRAIN

      Life sciences
    89. MCGREGOR IS; DASTUR FN; MCLELLAN RA; BROWN RE
      CANNABINOID MODULATION OF RAT PUP ULTRASONIC VOCALIZATIONS

      European journal of pharmacology
    90. MANEUF YP; NASH JE; CROSSMAN AR; BROTCHIE JM
      ACTIVATION OF THE CANNABINOID RECEPTOR BY DELTA(9)-TETRAHYDROCANNABINOL REDUCES GAMMA-AMINOBUTYRIC-ACID UPTAKE IN THE GLOBUS-PALLIDUS

      European journal of pharmacology
    91. ANDERSON JJ; KASK AM; CHASE TN
      EFFECTS OF CANNABINOID RECEPTOR STIMULATION AND BLOCKADE ON CATALEPSYPRODUCED BY DOPAMINE-RECEPTOR ANTAGONISTS

      European journal of pharmacology
    92. GUEUDET C; SANTUCCI V; RINALDICARMONA M; SOUBRIE P; LEFUR G
      THE CB1 CANNABINOID RECEPTOR ANTAGONIST SR 141716A AFFECTS A(9) DOPAMINE NEURONAL-ACTIVITY IN THE RAT

      NeuroReport
    93. SOUILHAC J; PONCELET M; RINALDICARMONA M; LEFUR G; SOUBRIE P
      INTRASTRIATAL INJECTION OF CANNABINOID RECEPTOR AGONISTS INDUCED TURNING BEHAVIOR IN MICE

      Pharmacology, biochemistry and behavior
    94. ACETO MD; SCATES SM; LOWE JA; MARTIN BR
      CANNABINOID PRECIPITATED WITHDRAWAL BY THE SELECTIVE CANNABINOID RECEPTOR ANTAGONIST, SR 141716A

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 22:25:23